pediatric-behavioral
Do Stimulants Affect a Child's Growth? What to Know
Stimulants can curb appetite and are linked to a small, usually modest slowing of growth in some children. Clinicians track height and weight so they can adjust the plan early if needed.
Talk to a clinician
Dr. Naomi Pearce, MD — Pediatrician
Tracks height and weight on growth charts during ADHD treatment, adjusts dose/timing or considers non-stimulants to protect growth, and weighs treatment benefit against growth for each child. Gale can match you with a licensed clinician for a visit.
Find care →What the concern actually is
The worry traces back to a real effect: stimulants commonly reduce appetite, and reviews consistently list decreased appetite as one of their most frequent side effects 1Ref 1Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015).Methylphenidate for Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD).Methylphenidate is associated with non-serious adverse events including decreased appetite.. Because eating and growth are connected, reduced appetite over time can be associated with a small slowing in weight gain, and in some children a modest effect on height velocity — most noticeable in the first year or two. This is different from saying stimulants "stunt growth" in every child; the effect is variable, often modest, and something clinicians watch for rather than ignore.
Why monitoring is the real answer
ADHD care is designed as ongoing management, not a one-time prescription. Professional guidelines treat children with ADHD as having a chronic condition that warrants regular follow-up 2Ref 2Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; AAP Subcommittee on Children and Adolescents with ADHD (2019).Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.The AAP recommends DSM-5-based diagnosis and treating ADHD as a chronic condition with ongoing follow-up, supporting routine growth monitoring during medication.. At those visits, the clinician plots height and weight on growth charts over time — a single measurement says little, but the trajectory across visits tells the story. If a child's growth curve dips, the clinician can respond before it becomes significant. Roughly half of children with current ADHD take medication, and this growth monitoring is a standard, well-established part of how it's done 3Ref 3Centers for Disease Control and Prevention (CDC) (2024).Data and Statistics on ADHD.About half of U.S. children with current ADHD take ADHD medication..
Steps that help
Practical adjustments often protect both appetite and growth: a substantial breakfast before the medication peaks, calorie-dense foods at dinner and in the evening when appetite returns, and reviewing dose timing so it isn't suppressing every meal. Clinicians may also consider medication holidays in some situations, lowering the dose, or switching agents — decisions that depend on the individual child and that a prescriber should guide. None of these are things to attempt alone, but they are the toolkit clinicians draw on.
Weighing benefit against the concern
It helps to hold both truths at once. Untreated ADHD carries its own costs — to learning, relationships, and self-esteem — and carefully managed medication is among the most effective treatments for core symptoms 4Ref 4MTA Cooperative Group (1999).A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder.Carefully titrated medication management was superior to behavioral therapy alone and community care for reducing core ADHD symptoms in the MTA trial.5Ref 5National Institute of Mental Health (NIMH) (2025).Attention-Deficit/Hyperactivity Disorder (ADHD).NIMH identifies medication and therapy as the most effective treatments for ADHD.. A small, monitored, often temporary effect on growth is weighed against that benefit, individually, with your clinician. For many families the right answer is to treat and watch growth closely, adjusting if needed, rather than to avoid treatment out of a concern that can be managed.
When a clinician helps
A clinician is essential here precisely because growth is a moving target that needs tracking. They plot height and weight on growth charts at every follow-up and interpret the trend rather than a single number, catching any slowing early 2Ref 2Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; AAP Subcommittee on Children and Adolescents with ADHD (2019).Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.The AAP recommends DSM-5-based diagnosis and treating ADHD as a chronic condition with ongoing follow-up, supporting routine growth monitoring during medication.. They adjust dose, timing, or formulation, or consider a non-stimulant or medication holiday to protect appetite and growth while preserving benefit. They confirm the ADHD diagnosis with DSM-5 criteria and validated tools so medication is warranted in the first place 2Ref 2Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; AAP Subcommittee on Children and Adolescents with ADHD (2019).Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.The AAP recommends DSM-5-based diagnosis and treating ADHD as a chronic condition with ongoing follow-up, supporting routine growth monitoring during medication., and they weigh the benefits of treating ADHD against the growth concern for your specific child — the kind of individualized judgment a web page can't give. If you're worried about growth, that is a reason to ask, not to stop on your own.
Common questions
Will my child catch up if growth slows?
For many children, any slowing is modest and growth often stabilizes or catches up over time, especially with monitoring and adjustments. Your clinician follows the growth chart trend over visits and intervenes if a real dip appears.
Do non-stimulant medications affect growth?
Non-stimulants have a different side-effect profile and are less associated with the appetite suppression that drives growth concerns. Your clinician can discuss whether one is a fit if growth is an issue.
Should I give my child medication breaks for growth?
Medication holidays are sometimes used, but whether they help your child — and whether the symptom cost is worth it — is an individual decision to make with your prescriber, not on your own.
Talk to a clinician
Dr. Naomi Pearce, MD — Pediatrician
Tracks height and weight on growth charts during ADHD treatment, adjusts dose/timing or considers non-stimulants to protect growth, and weighs treatment benefit against growth for each child. Gale can match you with a licensed clinician for a visit.
Find care →When to check in with your clinician
- —Noticeable or ongoing weight loss, or your child not eating
- —A drop or flattening you can see on your child's growth chart
- —Persistent loss of appetite that mealtime changes don't fix
This article is general education and not a substitute for personalized advice from your child's healthcare provider.
References
- 1.Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015). Methylphenidate for Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD). Cochrane Database of Systematic Reviews, Issue 11: CD009885. doi:10.1002/14651858.CD009885.pub2 ✓Methylphenidate is associated with non-serious adverse events including decreased appetite.
- 2.Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W; AAP Subcommittee on Children and Adolescents with ADHD (2019). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics, 144(4):e20192528. doi:10.1542/peds.2019-2528 ✓The AAP recommends DSM-5-based diagnosis and treating ADHD as a chronic condition with ongoing follow-up, supporting routine growth monitoring during medication.
- 3.Centers for Disease Control and Prevention (CDC) (2024). Data and Statistics on ADHD. Centers for Disease Control and Prevention (CDC). link ✓About half of U.S. children with current ADHD take ADHD medication.
- 4.MTA Cooperative Group (1999). A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Archives of General Psychiatry, 56(12):1073-1086. doi:10.1001/archpsyc.56.12.1073 ✓Carefully titrated medication management was superior to behavioral therapy alone and community care for reducing core ADHD symptoms in the MTA trial.
- 5.National Institute of Mental Health (NIMH) (2025). Attention-Deficit/Hyperactivity Disorder (ADHD). National Institute of Mental Health (NIMH) health topics. link ✓NIMH identifies medication and therapy as the most effective treatments for ADHD.
5 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.